Health Care Businesses

Lilly to end development of lupus drug after trial failure

October 2, 2014
Associated Press
Tabalumab was expected to generate about $250 million to $300 million a year in sales in several years.
More

IU Health CFO: 3 years to go in difficult transition

September 26, 2014
J.K. Wall
Kitchell Watch videoIn the past two years, IU Health has laid off 935 people, halted construction of a major bed tower, sold off health clinics and decided to close its proton-therapy center. But there are three more years of changes to come, said CFO Ryan Kitchell.
More

Major Health to put new $89 million hospital along I-74

September 24, 2014
J.K. Wall
Major Health Partners will construct the new hospital on the north edge of Shelbyville, after nearly a decade of shifting services to that location. Construction could begin next month.
More

Testosterone drugs need study on heart risks, FDA panel says

September 18, 2014
Bloomberg News
Drugmakers, including Eli Lilly and Co., should conduct new trials to assess the heart risks of testosterone therapies used by millions of men last year, advisers to U.S. regulators said.
More

Community Health plans $175M expansion of East facilities

September 17, 2014
J.K. Wall
Community executives said the investment and projects, which will begin this fall and extend over several years, prove their long-term commitment to the east side of the city.
More

FDA set to review testosterone-boosting drug usage

September 16, 2014
Bloomberg News
Testosterone supplements used last year by about 2.3 million men are spurring debates over how necessary and safe they may be, even as U.S. regulators consider approving a new product.
More

Recent wins worth $4B to Lilly market value

September 15, 2014
J.K. Wall
Lilly is finally putting meat on the bones of its predictions about its experimental diabetes and cancer drugs. That gives investors the certainty they crave that Lilly’s future revenue won’t remain in its 2014 doldrums.
More

Lilly execs make pitch for local preschool education

September 12, 2014
Jared Council
Eli Lilly and Co. executives on Friday repeated their plea to local businesses to support early childhood education, highlighting the work force development and crime-reduction benefits associated with the effort.
More

Lilly cancer drug fares well in late-stage study

September 12, 2014
Associated Press
Eli Lilly and Co. said Friday its potential colorectal cancer drug Cyramza helped patients on chemotherapy with advanced cases of the disease survive longer than patients on chemotherapy alone.
More

Lilly receives European marketing OK for new insulin

September 10, 2014
Associated Press
European regulators have approved a long-lasting insulin from Eli Lilly and Co. and German drugmaker Boehringer Ingelheim that is the subject of patent-infringement litigation with French rival Sanofi.
More

Lilly says new insulin fares better than rival's in late-stage tests

September 4, 2014
Associated Press
The Indianapolis-based drugmaker said Thursday that peglispro produced statistically significant lower blood sugar levels in patients when compared to people who took the Sanofi insulin Lantus in two late-stage studies of people with type 1 diabetes.
More

Feds: AIT's Evans 'unjustly enriched' himself in sale to employees

September 2, 2014
J.K. Wall
Just three months before the parent company of AIT Laboratories was sold in 2009 to its employees for $90 million, it was appraised for $17.1 million, according to a U.S. Department of Labor lawsuit.
More

Blood Center retrenches after losing major clients to Red Cross

August 30, 2014
J.K. Wall
The Indiana Blood Center is set to lose more than one-third of its revenue early next year, as three hospital systems bolt for cheaper prices offered by the American Red Cross.
More

Lilly, partner lose appeal to overturn $9 billion Actos court award

August 28, 2014
Bloomberg News
Takeda Pharmaceutical Co. and Eli Lilly and Co. lost a bid to have a judge throw out a combined $9 billion punitive-damage award over claims the drugmakers hid the cancer risks of their Actos diabetes medicine.
More

Franciscan cuts its way to higher profits

August 25, 2014
J.K. Wall
Franciscan Alliance, which operates three hospitals in the Indianapolis area, is seeing fewer patients this year but is making more money due to expense cuts.
More

EMS service to lay off 361 workers in Indiana

August 21, 2014
Mason King
Rural/Metro Corp. says the changing health care landscape and the challenges of covering rural communities are forcing it to end its area ambulance services. It's also closing a billing operations center in Indianapolis.
More

Lilly wins tentative approval for diabetes drug

August 20, 2014
 IBJ Staff
Final approval could be delayed until mid-2016 due to a claim of patent infringement by drugmaker Sanofi.
More

Cardinal Health unit seeks tax breaks for local drug facility

August 18, 2014
 IBJ Staff
A subsidiary of Dublin, Ohio-based Cardinal Health Inc. is seeking tax breaks from the city of Indianapolis to help it open a $14.4 million local drug-production facility that would employ 85 workers by 2017.
More

Lilly among those eyeing antibiotic maker Cubist, analyst says

August 18, 2014
Bloomberg News
The rising threat from drug-resistant germs and increasing calls from global health groups for more potent antibiotics is placing a premium on companies such as Cubist. The $4.8 billion drug developer is preparing to introduce four new medicines by 2020.
More

Eli Lilly to close Terre Haute animal enzyme plant

August 14, 2014
Associated Press
The plant closure will affect 23 plant employees, all of whom will be offered comparable positions at a Lilly plant near Clinton that employs about 500 workers.
More

Struggling hospital finds buyer, enters bankruptcy protection

August 12, 2014
 Bloomberg News and IBJ Staff
Bloomington’s Monroe Hospital, which has had a close relationship with Indianapolis-based St. Vincent Health, filed for bankruptcy reorganization on Friday and plans to sell its business to a Canadian operator.
More

FDA approves Lilly, Boehringer diabetes drug

August 1, 2014
Associated Press
The Food and Drug Administration said Friday it will permit Jardiance tablets to be used by adult patients with type 2 diabetes who also are trying to control their condition with diet and exercise.
More

Roche drug trial backs Lilly on Alzheimer’s findings

July 28, 2014
J.K. Wall
Results of a Roche clinical trial mirror those produced by an experimental Lilly drug two years ago. Lilly executives say that validates their approach in the multi-billion-dollar race to market the first drug to reverse Alzheimer's.
More

WellPoint CEO: Insurer preparing for technology wave

July 10, 2014
Associated Press
In a wide-ranging interview, WellPoint Inc. CEO Joseph Swedish says adapting to technology is a top priority as he leads the nation's second largest health insurer.
More

Medical device maker to hire 112 in Plainfield

July 1, 2014
Mason King
Global firm Covidien LP plans to consolidate U.S. operations for servicing its medical devices in central Indiana, renovating its existing 70,000-square-foot facility in the process.
More
Page  1 2 3 4 5 6 7 8 9 10 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
thisissue1-092914.jpg 092914

Subscribe to IBJ
  1. Cramer agrees...says don't buy it and sell it if you own it! Their "pay to play" cost is this issue. As long as they charge customers, they never will attain the critical mass needed to be a successful on company...Jim Cramer quote.

  2. My responses to some of the comments would include the following: 1. Our offer which included the forgiveness of debt (this is an immediate forgiveness and is not "spread over many years")represents debt that due to a reduction of interest rates in the economy arguably represents consideration together with the cash component of our offer that exceeds the $2.1 million apparently offered by another party. 2. The previous $2.1 million cash offer that was turned down by the CRC would have netted the CRC substantially less than $2.1 million. As a result even in hindsight the CRC was wise in turning down that offer. 3. With regard to "concerned Carmelite's" discussion of the previous financing Pedcor gave up $16.5 million in City debt in addition to the conveyance of the garage (appraised at $13 million)in exchange for the $22.5 million cash and debt obligations. The local media never discussed the $16.5 million in debt that we gave up which would show that we gave $29.5 million in value for the $23.5 million. 4.Pedcor would have been much happier if Brian was still operating his Deli and only made this offer as we believe that we can redevelop the building into something that will be better for the City and City Center where both Pedcor the citizens of Carmel have a large investment. Bruce Cordingley, President, Pedcor

  3. I've been looking for news on Corner Bakery, too, but there doesn't seem to be any info out there. I prefer them over Panera and Paradise so can't wait to see where they'll be!

  4. WGN actually is two channels: 1. WGN Chicago, seen only in Chicago (and parts of Canada) - this station is one of the flagship CW affiliates. 2. WGN America - a nationwide cable channel that doesn't carry any CW programming, and doesn't have local affiliates. (In addition, as WGN is owned by Tribune, just like WTTV, WTTK, and WXIN, I can't imagine they would do anything to help WISH.) In Indianapolis, CW programming is already seen on WTTV 4 and WTTK 29, and when CBS takes over those stations' main channels, the CW will move to a sub channel, such as 4.2 or 4.3 and 29.2 or 29.3. TBS is only a cable channel these days and does not affiliate with local stations. WISH could move the MyNetwork affiliation from WNDY 23 to WISH 8, but I am beginning to think they may prefer to put together their own lineup of syndicated programming instead. While much of it would be "reruns" from broadcast or cable, that's pretty much what the MyNetwork does these days anyway. So since WISH has the choice, they may want to customize their lineup by choosing programs that they feel will garner better ratings in this market.

  5. The Pedcor debt is from the CRC paying ~$23M for the Pedcor's parking garage at City Center that is apprased at $13M. Why did we pay over the top money for a private businesses parking? What did we get out of it? Pedcor got free parking for their apartment and business tenants. Pedcor now gets another building for free that taxpayers have ~$3M tied up in. This is NOT a win win for taxpayers. It is just a win for Pedcor who contributes heavily to the Friends of Jim Brainard. The campaign reports are on the Hamilton County website. http://www2.hamiltoncounty.in.gov/publicdocs/Campaign%20Finance%20Images/defaultfiles.asp?ARG1=Campaign Finance Images&ARG2=/Brainard, Jim

ADVERTISEMENT